Cystoscopy, an indispensable tool for the diagnosis and prognosis of bladder pain syndrome, takes nomograms for predicting recurrence.
Cystoscopy
Interstitial cystitis
Nomogram
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
20
05
2023
accepted:
30
06
2023
medline:
31
8
2023
pubmed:
16
7
2023
entrez:
15
7
2023
Statut:
ppublish
Résumé
We aimed to illustrate the importance of cystoscopy for the diagnosis and prognosis of bladder pain syndrome (BPS) or interstitial cystitis (IC). We designed a 4-year prospective follow-up study. Patients who underwent cystoscopy between May 2011 and July 2021 with a diagnosis of BPS/IC before surgery or positive cystoscopic findings during initial surgery at Peking University People's Hospital were enrolled. Data related to symptom recurrence were obtained through clinic visits and telephone follow-up. We compared the differences in clinical features of BPS/IC subtypes differentiated by cystoscopy and first created clinical predictive nomograms for BPS/IC. A total of 141 patients were included. There was an 8.51% chance of BPS/IC being misdiagnosed as other diseases or other diseases being misdiagnosed as BPS/IC without cystoscopy. Patients with HIC had higher pain scores and ICPI, higher residual urine volume, lower first-sense-to-void, and maximum cystometric bladder capacities than NHIC. Nomogram Models showed that patients who with higher ICPI, ICSI and lower AMBC have a greater recurrence probability, and lesions in the trigone may indicate a greater likelihood of recurrence than lesions in other bladder walls. Timely detection of bladder cancer and other diseases using cystoscopy can avoid poor treatment effects. BPS/IC subtypes can be classified according to mucosal changes under cystoscopy. Lesions in the bladder triangle can indicate a higher recurrence risk, which is important in follow-up treatment. We strongly recommend that cystoscopy should be included in the international BPS/IC diagnostic criteria.
Identifiants
pubmed: 37453960
doi: 10.1007/s00345-023-04517-6
pii: 10.1007/s00345-023-04517-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2451-2458Subventions
Organisme : Natural Science Research of Jiangsu Higher Education Institutions of China
ID : 81970660
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Homma Y, Akiyama Y, Tomoe H et al (2020) Clinical guidelines for interstitial cystitis/bladder pain syndrome. Int J Urol 27:578–589. https://doi.org/10.1111/iju.14234
doi: 10.1111/iju.14234
pubmed: 32291805
Wein AJ, Hanno PM, Gillenwater JY (1990) Interstitial cystitis: an introduction to the problem. In: Hanno PM, Staskin DR, Krane RJ, Wein AJ (eds) Interstitial Cystitis. Springer, London, pp 3–15
doi: 10.1007/978-1-4471-3293-6_1
Hanno PM, Landis JR et al (1999) The diagnosis of interstitial cystitis revisited: lessons learned from the national institutes of health interstitial cystitis database study. J Urol 161:553–557. https://doi.org/10.1016/S0022-5347(01)61948-7
doi: 10.1016/S0022-5347(01)61948-7
pubmed: 9915447
van de Merwe JP, Nordling J, Bouchelouche P et al (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53:60–67. https://doi.org/10.1016/j.eururo.2007.09.019
doi: 10.1016/j.eururo.2007.09.019
pubmed: 17900797
Hanno P, Lin A, Nordling J et al (2010) Bladder pain syndrome international consultation on incontinence. Neurourol Urodyn 29:191–198. https://doi.org/10.1002/nau.20847
doi: 10.1002/nau.20847
pubmed: 20025029
Hanno PM, Burks DA, Clemens JQ et al (2011) AUA Guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol 185:2162–2170. https://doi.org/10.1016/j.juro.2011.03.064
doi: 10.1016/j.juro.2011.03.064
pubmed: 21497847
pmcid: 9341322
Wein AJ (2004) Primary evaluation of patients suspected of having Interstitial Cystitis (IC). J Urol 172:2494–2495. https://doi.org/10.1016/S0022-5347(05)61463-2
doi: 10.1016/S0022-5347(05)61463-2
Ahn ST, Jeong HG, Park TY et al (2022) Cancer statistics, 2022. CA A Cancer J Clin 72:7–33. https://doi.org/10.3322/caac.21708
doi: 10.3322/caac.21708
Fall M, Johansson SL, Aldenborg F (1987) chronic interstitial cystitis: a heterogeneous syndrome. J Urol 137:35–38. https://doi.org/10.1016/S0022-5347(17)43863-8
doi: 10.1016/S0022-5347(17)43863-8
pubmed: 3795363
Nickel JC, Doiron RC (2020) Hunner lesion interstitial cystitis: the bad, the good, and the unknown. Eur Urol 78:e122–e124. https://doi.org/10.1016/j.eururo.2020.04.067
doi: 10.1016/j.eururo.2020.04.067
pubmed: 32507337
Han J, Shin JH, Choo M (2019) Patterns and predictors of Hunner lesion recurrence in patients with interstitial cystitis. Neurourol Urodyn 38:1392–1398. https://doi.org/10.1002/nau.23998
doi: 10.1002/nau.23998
pubmed: 30945347
Ronstrom C, Lai HH (2020) Presenting an atlas of Hunner lesions in interstitial cystitis which can be identified with office cystoscopy. Neurourol Urodyn 39:2394–2400. https://doi.org/10.1002/nau.24500
doi: 10.1002/nau.24500
pubmed: 32902893
Doiron RC, Tolls V, Irvine-Bird K et al (2016) Clinical phenotyping does not differentiate hunner lesion subtype of interstitial cystitis/bladder pain syndrome: a relook at the role of cystoscopy. J Urol 196:1136–1140. https://doi.org/10.1016/j.juro.2016.04.067
doi: 10.1016/j.juro.2016.04.067
pubmed: 27117441
Ahn ST, Jeong HG, Park TY et al (2018) Differences in urodynamic parameters according to the presence of a hunner lesion in women with interstitial cystitis/bladder pain syndrome. CA A Cancer J Clin 22:S55-61. https://doi.org/10.5213/inj.1835044.522
doi: 10.5213/inj.1835044.522
Peeker R (2002) Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease. J Urol 167:2470–2472. https://doi.org/10.1016/S0022-5347(05)65006-9
doi: 10.1016/S0022-5347(05)65006-9
pubmed: 11992059